Form4insider filings, from the source

SEC Form 3 · accession 0002137663-26-000003

Zura Bio Ltd · ZURA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Marlyn Teresa Mathew
Officer — VP, Principal Acctg. Officer
Period of report
Apr 17, 2026
Accepted (ET)
Jun 22, 2026 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001855644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Ordinary SharesF1holding———129,182D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Share Option (Right to Buy)F3,F2—holding————Jun 8, 2032Class A Ordinary Shares37,505—D
Employee Share Option (Right to Buy)F5,F4—holding————Mar 15, 2033Class A Ordinary Shares11,133—D
Employee Share Option (Right to Buy)F6$3.38holding————Jun 18, 2034Class A Ordinary Shares90,000—D
Employee Share Option (Right to Buy)F7$1.20holding————Feb 27, 2035Class A Ordinary Shares81,150—D
Employee Share Option (Right to Buy)F8$6.03holding————Apr 1, 2036Class A Ordinary Shares66,220—D

Explanation of responses